These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28039301)

  • 1. IL-6 Inhibits Upregulation of Membrane-Bound TGF-β 1 on CD4+ T Cells and Blocking IL-6 Enhances Oral Tolerance.
    Kuhn C; Rezende RM; M'Hamdi H; da Cunha AP; Weiner HL
    J Immunol; 2017 Feb; 198(3):1202-1209. PubMed ID: 28039301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance.
    Neurath MF; Fuss I; Kelsall BL; Presky DH; Waegell W; Strober W
    J Exp Med; 1996 Jun; 183(6):2605-16. PubMed ID: 8676081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo anti-LAP mAb enhances IL-17/IFN-γ responses and abrogates anti-CD3-induced oral tolerance.
    da Cunha AP; Wu HY; Rezende RM; Vandeventer T; Weiner HL
    Int Immunol; 2015 Feb; 27(2):73-82. PubMed ID: 25194146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal immunization with heat shock protein 60 induces CD4(+) CD25(+) GARP(+) and type 1 regulatory T cells and inhibits early atherosclerosis.
    Zhong Y; Tang H; Wang X; Zeng Q; Liu Y; Zhao XI; Yu K; Shi H; Zhu R; Mao X
    Clin Exp Immunol; 2016 Mar; 183(3):452-68. PubMed ID: 26452441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β induces surface LAP expression on murine CD4 T cells independent of Foxp3 induction.
    Oida T; Weiner HL
    PLoS One; 2010 Nov; 5(11):e15523. PubMed ID: 21124798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of Anti-LAP Monoclonal Antibody Down-regulation of CD4+LAP+ T Cells on Allogeneic Corneal Transplantation in Mice.
    Li S; Lu H; Sella R; Zhang W; Dong H; Guo C; Afshari NA; Pan Z; Jie Y
    Sci Rep; 2018 May; 8(1):8021. PubMed ID: 29789580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible CD4+LAP+Foxp3- regulatory T cells suppress allergic inflammation.
    Duan W; So T; Mehta AK; Choi H; Croft M
    J Immunol; 2011 Dec; 187(12):6499-507. PubMed ID: 22079987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+CD25- T cells that express latency-associated peptide on the surface suppress CD4+CD45RBhigh-induced colitis by a TGF-beta-dependent mechanism.
    Oida T; Zhang X; Goto M; Hachimura S; Totsuka M; Kaminogawa S; Weiner HL
    J Immunol; 2003 Mar; 170(5):2516-22. PubMed ID: 12594277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary role of CD4+CD25+ regulatory T cells and TGF-beta in oral tolerance.
    Chung Y; Lee SH; Kim DH; Kang CY
    J Leukoc Biol; 2005 Jun; 77(6):906-13. PubMed ID: 15758078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity in FoxP3- and GARP/LAP-Expressing T Regulatory Cells in an HLA Class II Transgenic Murine Model of Necrotizing Soft Tissue Infections by Group A Streptococcus.
    Nookala S; Mukundan S; Fife A; Alagarsamy J; Kotb M
    Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30224551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1α,25-dihydroxyvitamin D3 acts via transforming growth factor-β to up-regulate expression of immunosuppressive CD73 on human CD4+ Foxp3- T cells.
    Mann EH; Chambers ES; Chen YH; Richards DF; Hawrylowicz CM
    Immunology; 2015 Nov; 146(3):423-31. PubMed ID: 26251265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
    Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
    J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The GARP/Latent TGF-β1 complex on Treg cells modulates the induction of peripherally derived Treg cells during oral tolerance.
    Edwards JP; Hand TW; Morais da Fonseca D; Glass DD; Belkaid Y; Shevach EM
    Eur J Immunol; 2016 Jun; 46(6):1480-9. PubMed ID: 27062243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ CD25+ transforming growth factor-beta-producing T cells are present in the lung in murine tuberculosis and may regulate the host inflammatory response.
    Mason CM; Porretta E; Zhang P; Nelson S
    Clin Exp Immunol; 2007 Jun; 148(3):537-45. PubMed ID: 17362490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis.
    Sun JB; Czerkinsky C; Holmgren J
    J Immunol; 2012 Feb; 188(4):1686-97. PubMed ID: 22250081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing effects of TGF-beta 2 on the Th1 cell development of naive CD4+ T cells isolated from different mouse strains.
    Hoehn P; Goedert S; Germann T; Koelsch S; Jin S; Palm N; Ruede E; Schmitt E
    J Immunol; 1995 Oct; 155(8):3788-93. PubMed ID: 7561083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factor early growth response 3 is associated with the TGF-β1 expression and the regulatory activity of CD4-positive T cells in vivo.
    Sumitomo S; Fujio K; Okamura T; Morita K; Ishigaki K; Suzukawa K; Kanaya K; Kondo K; Yamasoba T; Furukawa A; Kitahara N; Shoda H; Shibuya M; Okamoto A; Yamamoto K
    J Immunol; 2013 Sep; 191(5):2351-9. PubMed ID: 23904169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble GARP has potent antiinflammatory and immunomodulatory impact on human CD4⁺ T cells.
    Hahn SA; Stahl HF; Becker C; Correll A; Schneider FJ; Tuettenberg A; Jonuleit H
    Blood; 2013 Aug; 122(7):1182-91. PubMed ID: 23818544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.